There are growing concerns that Merck and potentially other pharmaceutical giants are working behind the scenes to shut down all generic production of ivermectin, particularly in India where more than 50 different companies currently manufacture it for the global market.
Dr. Kazuhiro Nagao, chair
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek